Results 1 to 10 of about 202,042 (259)

Confirmed Autochthonous Case of Human Alveolar Echinococcosis, Italy, 2023 [PDF]

open access: yesEmerging Infectious Diseases
In September 2023, a patient in Italy who had never traveled abroad was referred for testing for suspected hepatic cystic echinococcosis. Lesions were incompatible with cystic echinococcosis; instead, autochthonous alveolar echinococcosis was confirmed.
Francesca Tamarozzi   +6 more
doaj   +3 more sources

Kidney invasion occurred 2 years following liver transplantation for hepatic alveolar echinococcosis: a case report [PDF]

open access: yesBMC Infectious Diseases, 2023
Background The organ most commonly invaded in echinococcosis is the liver; the lungs, brain, kidneys, heart, and spleen are rarely invaded, and multi-organ involvement in echinococcosis is even rarer.
Qirui Hu   +5 more
doaj   +3 more sources

Human Alveolar Echinococcosis, Croatia [PDF]

open access: yesEmerging Infectious Diseases, 2020
Alveolar echinococcosis is a parasitic disease caused by the tapeworm larval stage of Echinococcus multilocularis. This zoonotic disease has not been known to occur in Croatia.
Davorka Dušek   +6 more
doaj   +6 more sources

Hepatic alveolar echinococcosis: a diagnostic challenge [PDF]

open access: goldJournal of the Belgian Society of Radiology, 2011
We report a case of alveolar echinococcosis involving the liver in a 61-year-old male. Alveolar echinococcosis is a rare chronic and progressive disease, which can involve mostly liver and in rare cases lung and brain.
O Yapici   +6 more
doaj   +7 more sources

Epidemiological characteristics and risk factors for cystic and alveolar echinococcosis in China: an analysis of a national population-based field survey

open access: yesParasites & Vectors, 2023
Background Human cystic and alveolar echinococcosis are neglected tropical diseases that WHO has prioritized for control in recent years. Both diseases impose substantial burdens on public health and the socio-economy in China.
Tian Ma   +21 more
doaj   +2 more sources

Advances in the pharmacological treatment of hepatic alveolar echinococcosis: From laboratory to clinic

open access: yesFrontiers in Microbiology, 2022
Hepatic alveolar echinococcosis (HAE) is a zoonotic parasitic disease caused by the larvae of Echinococcus multilocularis. Because of its characteristics of diffuse infiltration and growth similar to tumors, the disability rate and mortality rate are ...
Xiaolei Xu   +37 more
doaj   +2 more sources

Alveolar echinococcosis in immunocompromised hosts.

open access: yesClinical Microbiology and Infection, 2022
Alveolar echinococcosis (AE) results of an infection with the larval stage of Echinococcus multilocularis. It has been increasingly described in individuals with impaired immune responsiveness.This narrative review aims at describing the presentation of AE according to the type of immune impairment, based on retrospective cohorts and case reports ...
B. Autier   +7 more
semanticscholar   +6 more sources

Characteristics of the imaging diagnosis of alveolar echinococcosis. [PDF]

open access: yesWorld J Gastrointest Surg
Alveolar echinococcosis (AE) primarily manifests in the liver and exhibits characteristics resembling those of slow-growing malignant tumours. Untreated Echinococcus multilocularis infection can be lethal.
Aydin S   +4 more
europepmc   +2 more sources

Alveolar echinococcosis.

open access: yesTidsskrift for Den norske legeforening
Alveolar echinococcosis is a much-feared parasitic zoonosis caused by the larval stage of Echinococcus multilocularis. Mainland Norway is free from infection, but alveolar echinococcosis is, on rare occasions, imported from endemic regions.
Mogens Jensenius   +10 more
semanticscholar   +3 more sources

Prediction of benzimidazole therapy duration with PET/CT in inoperable patients with alveolar echinococcosis

open access: yesScientific Reports, 2022
Alveolar echinococcosis is a rare parasitic disease, most frequently affecting the liver, as a slow-growing tumor-like lesion. If inoperable, long-term benzimidazole therapy is required, which is associated with high healthcare costs and occasionally ...
Lars Husmann   +11 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy